摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

IrH5(P-(i-Pr)3)2 | 53470-70-5

中文名称
——
中文别名
——
英文名称
IrH5(P-(i-Pr)3)2
英文别名
——
IrH5(P-(i-Pr)3)2化学式
CAS
53470-70-5
化学式
C18H47IrP2
mdl
——
分子量
517.739
InChiKey
LTYZATLVTIBZFZ-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    6.05
  • 重原子数:
    21.0
  • 可旋转键数:
    8.0
  • 环数:
    0.0
  • sp3杂化的碳原子比例:
    1.0
  • 拓扑面积:
    0.0
  • 氢给体数:
    0.0
  • 氢受体数:
    0.0

反应信息

  • 作为反应物:
    参考文献:
    名称:
    氢化铱配合物的反应模式和催化化学
    摘要:
    [IrH 5 P 2 ](1,PPPr i 3)与CF 3 COOR(RCH 2 CF 3)在60°C下于以下条件下在环-C 6 D 12中自催化反应:1 + CF 3 COOR→[ IrH 2 P 2(OR)](2)+ ROH(4)(等式1)。比率定律- = k [ 1 ] [CF 3 COOR] [ 2 ] [ 4 ] -(k = 1.25×10-4中号-秒-1),是与所述机构相一致,1 + 2 ⇌2 [IRH 3 P 2 ](5)+ 4(快速平衡); 5 + CF 3 COOR→[IrH 2 P 2 {OCH(OR)CF 3 }](6)(速率确定);6 → 2 + CF 3 CHO; 5 + CF 3 CHO→ 2。2用H迅速反应2:根据(25℃,1个大气压)2 + 2小时2→ 1 + 4(等式2)。尽管反应1和2的组合构成了CF 3 COOR加氢的催化循环(CF 3 COOR +
    DOI:
    10.1016/0022-328x(90)85230-v
  • 作为产物:
    描述:
    trans-Ir(IV)(H)2(Cl)2(P-i-Pr3)2苄基三乙基氯化铵氢气 作用下, 以 sodium hydroxide 为溶剂, 以>90的产率得到IrH5(P-(i-Pr)3)2
    参考文献:
    名称:
    Generation of incompletely coordinated complexes of iridium and metal complex activation of molecular hydrogen under phase transfer catalysis
    摘要:
    DOI:
    10.1007/bf00957470
  • 作为试剂:
    描述:
    丙烯腈α-甲基苯腈IrH5(P-(i-Pr)3)2 作用下, 以 四氢呋喃 为溶剂, 反应 20.0h, 以94%的产率得到3-苯基-3-甲基哌啶-2,6-二酮
    参考文献:
    名称:
    过渡金属基路易斯酸和氢化铱配合物的碱性两性催化剂:戊二酰亚胺的多组分合成。
    摘要:
    DOI:
    10.1002/anie.200351689
点击查看最新优质反应信息

文献信息

  • A Series of Hydrido(vinyl)iridium(III) Complexes That Are Thermodynamically More Stable than Their Olefin Iridium(I) Isomers
    作者:Thomas Dirnberger、Helmut Werner
    DOI:10.1021/om0505099
    日期:2005.10.1
    O)-C6H4C(CHCHPh)O}(PiPr3)2] (20), which were separated by column chromatography. From trans-[IrCl(C8H14)(PiPr3)2] and acrylic acid both [IrH(Cl)-κ2(C,O)-CHCHC(OH)O}(PiPr3)2] (21) and [IrH(Cl)κ2(O,O)-O2CCHCH2}(PiPr3)2] (22) were obtained. While the attempted hydrogenation of [IrH(Cl)κ2(C,O)-CHCHC(Me)O}(PiPr3)2] (2) with Pd/C as the catalyst led to the formation of [IrH2(Cl)(PiPr3)2] (24) and ethyl methyl
    原位生成的环辛烯(I)衍生物反式-[IrCl(C 8 H 14)(P i Pr 3)2 ]与甲基乙烯基和其他迈克尔体系RCH C(R')C(O)R的反应''(R = H,Me,Ph,OMe; R'= H,Me,i Pr; R''= H,Me,OMe,NH 2,NMe 2)导致八面体氢化物乙烯基)的形成(III)配合物[IRH(CL)κ 2(C ^,ö)-C(R)C(R ')C(R'“)Ô}(P我3)2 ](2 - 13)中的乙烯基配体以双齿形式进行配位。的治疗反式- [的IrCl(C 8 H ^ 14)(P我3)2 ]与丙烯酸和任一富马酸二甲酯或得到(I)马来酸二甲酯化合物的反式- [的IrCl(η 2 -RCH CHCO 2 Me)的(P我3)2 ](15,16),该热或光化学重排为热力学更稳定的(III)的异构体[IRH(CL)κ 2(C ^,ö)-C(R)CHC(OME)ø}(P我3)2
  • N–H and C–H Bond Activations of an Isoindoline Promoted by Iridium- and Osmium-Polyhydride Complexes: A Noninnocent Bridge Ligand for Acceptorless and Base-Free Dehydrogenation of Secondary Alcohols
    作者:María L. Buil、Miguel A. Esteruelas、Susana Izquierdo、Antonio I. Nicasio、Enrique Oñate
    DOI:10.1021/acs.organomet.0c00316
    日期:2020.7.27
    and the corresponding alkoxide. The mononuclear complex 3 and the binuclear compounds 4 and 5 are efficient catalysts for the acceptorless and base-free dehydrogenation of secondary alcohols. The binuclear complexes 4 and 5 are significantly more active than 3. The catalytic synergism is a consequence of the mutual electronic influence of the metals through the bridge. X-ray diffraction analysis data
    已经通过使用多元醇IrH 5进行了许多生物活性分子中所含有机片段的难以捉摸的C H键活化以及在双属催化中将所得非纯配体用于仲醇的无受体和无碱脱的应用( P i Pr 3)2(1)和OsH 6(P i Pr 3)2(2)。复杂1激活的1,3-双的N-H键(6'-甲基吡啶-2'-亚基)异吲哚啉(HBMePHI),得到单核配合物IRH 2 κ 2 - Ñ,Ñ亚胺(BMePHI)}(P我3)2(3)。既1和2活化C(SP 2)-H键在BMePHI的配体异吲哚啉核心的4位3。该反应导致homobinuclear复杂(P我3)2 ħ 2的Ir μ-(κ 2 - Ñ PY,Ñ亚胺-BMePI-κ 2 - Ñ亚胺,Ç 4异)} IRH 2(P我3) 2( 4)和所述异双化合物(P我3) 2 ħ 2的Ir μ-(κ 2 - Ñ PY, Ñ亚胺-BMePI-κ 2 - Ñ亚胺, Ç 4异)}
  • Vinyliden-Übergangsmetallkomplexe
    作者:A. Höhn、H. Werner
    DOI:10.1016/0022-328x(90)85231-m
    日期:1990.2
    XVa–c; X  I : XVIa–c; X  CH3 : XVIIa, c), are prepared from XIa–c by ligand displacement using KOH, NaI and LiCH3 as reagents. trans-[IrI(CCH2)(PPr3i)2] (XVIa) reacts with CO to give the octahedral alkynyl(hydrido)iridium(III) complex [IrH(C2H)I(PPr3i)2(CO)] (XVIII). From XIc and XIa as starting materials, the vinyl iridium(III) compounds [IrH2(CHCHPh)(PPr3i)2(CO)] (XIX) and [Ir(CMeCH2)Cl(I)(PPr3i)2]
    反式-[IrCl(CCHR)(PPr 3 i)2 ](XIa–c)的方形平面亚乙烯基(I)络合物是由反式-[IrCl(HCCR)(PPr 3)i)2 ](VIIIa–c)通过分离的(对于RMe,Ph)炔基((III)异构体[IrH(C 2 R)Cl(PPr 3 i)2 ](IXb,c)。的反应〔的IrCl(C 8 H ^ 14)2 ] 2和PPR 3我与HCCSiPh 3根直接形成引线[IRH(C 2 SIPH 3)Cl(PPr 3 i)2 ](IXe)。亚乙烯基配合物XIa–c与HBF 4反应,首先生成[IrHCl(CCHR)(PPr 3 i)2 ] +(XIIa–c),然后通过分子内重排得到阳离子的BF 4盐。反式- [的IrCl(CCH 2 R)(PPR 3我)2 ] +(XIIIa的-C)。在解决方案中,XIIIa–c和XIIa–c之间存在平衡,而该平
  • Osmium- and Iridium-Promoted C–H Bond Activation of 2,2′-Bipyridines and Related Heterocycles: Kinetic and Thermodynamic Preferences
    作者:Lara Cancela、Miguel A. Esteruelas、Ana M. López、Montserrat Oliván、Enrique Oñate、Ainhoa San-Torcuato、Andrea Vélez
    DOI:10.1021/acs.organomet.0c00156
    日期:2020.6.8
    The d2-hexahydride complex OsH6(PiPr3)2 (1) promotes the activation of C–H bonds of 2,2′-bipyridines and related heterocycles. The study of the same reactions with the deuteride counterpart OsD6(PiPr3)2 (1-d) reveals that the activation of the C–H bonds situated in the sterically less hindered positions is kinetically preferred. However, the isolated products are the result of the thermodynamic control
    该d 2 -hexahydride复杂OSH 6(P我3)2(1)促进的2,2'-联吡啶和相关的杂环C-H键活化。对与代对应物OSD 6(P i Pr 3)2(1 - d)进行的相同反应的研究表明,在空间上受阻位置上的C–H键的活化在动力学上是优选的。但是,分离出的产物是反应热力学控制的结果。因此,反应1与2,2'-联吡啶6-苯基-2,2'-联吡啶,和6-甲基-2,2'-联吡啶,得到“翻转环属化”产品OSH 3 κ 2 - Ç,ñ - [C 5(R)H 2 N-py]}(P i Pr 3)2(R = H(2),Ph(3),Me(4)),而3,5-二甲基-6-基-2,2 '联吡啶,得到OSH 2 κ 3 - ç,ñ,ç - [C 5 H ^ 3 N-(Me)的2 PY-C 5 H ^ 4]}(P i Pr 3)2(5),含有双阴离子C,N,C-钳位配体。底物吡啶基-苯并咪唑鎓和
  • Synthesis and Migratory Insertion Reactions of (Vinylidene)iridium Complexes <i>trans</i>-[IrX(CCRR‘)(P<i>i</i>Pr<sub>3</sub>)<sub>2</sub>] Containing Alkyl, Aryl, Alkynyl, and Azide Ligands<sup>,</sup><sup>1</sup>
    作者:Helmut Werner、Kerstin Ilg、Birgit Weberndörfer
    DOI:10.1021/om990874y
    日期:2000.8.1
    trans-[IrCl(CCRR‘)(PiPr3)2] (1, 4) react with organolithium compounds R‘ ‘Li by chloride substitution to afford the organoiridium(I) derivatives trans-[IrR‘ ‘(CCRR‘)(PiPr3)2] (5−8) in excellent yields. In contrast, treatment of 1 (R = SiMe3, R‘ = Me) with Grignard reagents R‘ ‘MgX leads to halide metathesis and formation of the bromo- and iodoiridium(I) compounds trans-[IrXCC(SiMe3)Me}(PiPr3)2] (X = Br, I),
    的(亚乙烯基(I)配合物的反式- [的IrCl(ç CRR ')(P我3)2 ](1,4)与有机锂化合物中,R反应'“李通过酰替代,得到organoiridium(I)衍生物反式- [IRR” '(ç CRR')(P我3)2 ](5 - 8)以优良产率。相反,用格氏试剂R''MgX处理1(R = SiMe 3,R'= Me)会导致卤化物易位并形成反式的(I)化合物- [IRX Ç C(森达3)Me}(P我3)2 ]分别(X = Br的,I),。炔基配合物反式-[Ir(C⋮CR)(C CHPh)(P i Pr 3)2 ](R = Ph,CO 2 Me)由反式-[Ir(OH)(C CHPh)(P i Pr 3)2 ]和游离炔。化合物的治疗5 - 8和12用CO发起洄游插入过程这给η 1-乙烯基配合物的反式- [η 1 - (ż)-C(R” ')CRR'}(CO)(P我3)2
查看更多

同类化合物

()-2-(5-甲基-2-氧代苯并呋喃-3(2)-亚乙基)乙酸乙酯 (双(2,2,2-三氯乙基)) (乙基N-(1H-吲唑-3-基羰基)ethanehydrazonoate) (Z)-3-[[[2,4-二甲基-3-(乙氧羰基)吡咯-5-基]亚甲基]吲哚-2--2- (S)-(-)-5'-苄氧基苯基卡维地洛 (S)-(-)-2-(α-(叔丁基)甲胺)-1H-苯并咪唑 (S)-(-)-2-(α-甲基甲胺)-1H-苯并咪唑 (S)-氨氯地平-d4 (S)-8-氟苯并二氢吡喃-4-胺 (S)-4-(叔丁基)-2-(喹啉-2-基)-4,5-二氢噁唑 (S)-4-氯-1,2-环氧丁烷 (S)-3-(2-(二氟甲基)吡啶-4-基)-7-氟-3-(3-(嘧啶-5-基)苯基)-3H-异吲哚-1-胺 (S)-2-(环丁基氨基)-N-(3-(3,4-二氢异喹啉-2(1H)-基)-2-羟丙基)异烟酰胺 (SP-4-1)-二氯双(喹啉)-钯 (SP-4-1)-二氯双(1-苯基-1H-咪唑-κN3)-钯 (R,S)-可替宁N-氧化物-甲基-d3 (R,S)-六氢-3H-1,2,3-苯并噻唑-2,2-二氧化物-3-羧酸叔丁酯 (R)-(+)-5'-苄氧基卡维地洛 (R)-(+)-2,2'',6,6''-四甲氧基-4,4''-双(二苯基膦基)-3,3''-联吡啶(1,5-环辛二烯)铑(I)四氟硼酸盐 (R)-卡洛芬 (R)-N'-亚硝基尼古丁 (R)-DRF053二盐酸盐 (R)-4-异丙基-2-恶唑烷硫酮 (R)-3-甲基哌啶盐酸盐; (R)-2-苄基哌啶-1-羧酸叔丁酯 (N-(Boc)-2-吲哚基)二甲基硅烷醇钠 (N-{4-[(6-溴-2-氧代-1,3-苯并恶唑-3(2H)-基)磺酰基]苯基}乙酰胺) (E)-2-氰基-3-(5-(2-辛基-7-(4-(对甲苯基)-1,2,3,3a,4,8b-六氢环戊[b]吲哚-7-基)-2H-苯并[d][1,2,3]三唑-4-基)噻吩-2-基)丙烯酸 (E)-2-氰基-3-[5-(2,5-二氯苯基)呋喃-2-基]-N-喹啉-8-基丙-2-烯酰胺 (8α,9S)-(+)-9-氨基-七氢呋喃-6''-醇,值90% (6R,7R)-7-苯基乙酰胺基-3-[(Z)-2-(4-甲基噻唑-5-基)乙烯基]-3-头孢唑啉-4-羧酸二苯甲基酯 (6-羟基嘧啶-4-基)乙酸 (6,7-二甲氧基-4-(3,4,5-三甲氧基苯基)喹啉) (6,6-二甲基-3-(甲硫基)-1,6-二氢-1,2,4-三嗪-5(2H)-硫酮) (5aS,6R,9S,9aR)-5a,6,7,8,9,9a-六氢-6,11,11-三甲基-2-(2,3,4,5,6-五氟苯基)-6,9-甲基-4H-[1,2,4]三唑[3,4-c][1,4]苯并恶嗪四氟硼酸酯 (5R,Z)-3-(羟基((1R,2S,6S,8aS)-1,3,6-三甲基-2-((E)-prop-1-en-1-yl)-1,2,4a,5,6,7,8,8a-八氢萘-1-基)亚甲基)-5-(羟甲基)-1-甲基吡咯烷-2,4-二酮 (5E)-5-[(2,5-二甲基-1-吡啶-3-基-吡咯-3-基)亚甲基]-2-亚磺酰基-1,3-噻唑烷-4-酮 (5-(4-乙氧基-3-甲基苄基)-1,3-苯并二恶茂) (5-溴-3-吡啶基)[4-(1-吡咯烷基)-1-哌啶基]甲酮 (5-氯-2,1,3-苯并噻二唑-4-基)-氨基甲氨基硫代甲酸甲酯一氢碘 (5-氨基-6-氰基-7-甲基[1,2]噻唑并[4,5-b]吡啶-3-甲酰胺) (5-氨基-1,3,4-噻二唑-2-基)甲醇 (4aS-反式)-八氢-1H-吡咯并[3,4-b]吡啶 (4aS,9bR)-6-溴-2,3,4,4a,5,9b-六氢-1H-吡啶并[4,3-B]吲哚 (4S,4''S)-2,2''-环亚丙基双[4-叔丁基-4,5-二氢恶唑] (4-(4-氯苯基)硫代)-10-甲基-7H-benzimidazo(2,1-A)奔驰(德)isoquinolin-7一 (4-苄基-2-甲基-4-nitrodecahydropyrido〔1,2-a][1,4]二氮杂) (4-甲基环戊-1-烯-1-基)(吗啉-4-基)甲酮 (4-己基-2-甲基-4-nitrodecahydropyrido〔1,2-a][1,4]二氮杂) (4,5-二甲氧基-1,2,3,6-四氢哒嗪)